Skip to content
Logo UroCCR fond blanc

News

Resources

Database
  • French
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
Contact

News

Resources

Database
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
Contact

Phase: Ongoing

Monitoring of atypical renal cysts

Comparison of clinical and oncological outcomes of transperitoneal versus retroperitoneal robot-assisted partial nephrectomy in obese patients: a multi-institutional matched-pair analysis

Comparison of clinical and oncological outcomes of transperitoneal versus retroperitoneal robot-assisted partial nephrectomy for complex renal tumours: a multi-institutional matched-pair analysis.

Partial Nephrectomy: Evaluation of Robot-Assisted Surgery vs. Laparotomy

Robot-assisted off-clamp partial nephrectomy: what are the benefits for preserving kidney function?

Study of treatment sequences following first-line immunotherapy for advanced or metastatic clear cell renal cell carcinoma: data from the UroCCR registry

External validation of an algorithm for managing small kidney masses based on renal biopsy.

Identification and description of patients at high risk of renal carcinoma recurrence.

Optimization of the surgical care pathway for kidney tumors through digitization of perioperative nursing coordination.

Validation of a predictive model developed at Gregorio Marañon University Hospital (Madrid) for the recurrence of localized kidney cancer at 3.5 and 8 years of follow-up, based on post-surgical pathological variables in patients treated with nephrectomy.

← Previous
Next →
Cercle rouge UroCCR Bordeaux
Cercle bleu UroCCR Bordeaux
Logo UroCCR
  • Address

Department of Urology
Bordeaux University Hospital Centre
Place Amélie Raba-Léon 33076 Bordeaux cedex

  • Telephone │+33 05 57 82 12 94
  • E-MAIL │uroccr@chu-bordeaux.fr
  • FAX │+33 05 56 79 56 51
Linkedin-in Youtube X-twitter

Legal notices

Privacy policy

Copyright © 2026 UroCCR
  • French